ADAM17 and neoplasm: The current study focused on the target gene ADAM17, which acts as a molecular switch for controlling immune responses, tissue regeneration and cancer development.46ADAM17 is expressed and upregulated in tumor cells almost ubiquitously47 and is rarely reported in fibrotic diseases.